News | June 10, 2015

Russia's First Private PET Diagnostics, High-accuracy Radiotherapy Departments Open in Moscow

Group of Companies European Medical Center now offers comprehensive oncologic protocol including screening, diagnostics, chemotherapy and radiotherapy

GEMC, PET-CT, pharmaceuticals, Institute of Oncology, radiotherapy, Moscow

June 10, 2015 - In May, Group of Companies European Medical Center (GEMC) became the first private clinic in Russia to open a positron emission tomography (PET-CT) department producing its own pharmaceuticals. GEMC also opened a radiation cancer therapy department featuring two linear accelerators.

GEMC has thus created an Institute of Oncology unprecedented among private clinics in Russia, implementing a comprehensive oncologic protocol - from screening and high-accuracy diagnostics (PET/CT, magnetic resonance imaging, pathomorphology, immunohistochemistry, genetic testing) to chemotherapy and radiotherapy, da Vinci robot-assisted surgery, provision of psychological support for patients and their families, palliative care and pain treatment.

"The project received over ten favorable decisions and permits on security from regulatory bodies and expert organizations. All facilities are equipped with modern radiometric and radiation-monitoring equipment certified in Russia according to national and international standards," stated Leonid Shayman, GEMC board member responsible for the creation of the PET-CT and the Radiation Therapy Departments.

"The main advantage of the equipment is its ability to apply more intense radiation exposure in less time, greatly increasing the effectiveness of treatment, while reducing the length and number of sessions. The department provides round-the-clock emergency radiotherapy for oncologic emergencies, and radiation treatment of cancer in children over three," added Shayman.

The PET-CT and Radiotherapy Center is located at the multifunctional GEMC hospital in Moscow. The total amount invested is 1.35 billion rubles. The annual capacity of PET-CT Diagnostics Center is 6,000 patients; the radiation therapy department capacity is 25,000 patients.

The Department of Radionuclide Diagnostics is equipped with PET-CT and Philips Gemini computed tomography (CT) systems and the single-photon emission computed tomography (SPECT) Philips Brightview XCT system. The department features a cyclotron by IBA that produces its own PET-CT radiopharmaceuticals. The extended quality control laboratory, equipped with the most modern equipment, is operational. A research technique on sentinel lymph node for breast cancer and melanoma is applied. An expansion of radiopharmaceutical production choline and tyrosine applied in oncourology and neurosurgery is planned in autumn 2015.

The Department of Radiotherapy is equipped with TrueBeam and Trilogy linear accelerators by Varian. Treatment is performed by highly skilled professionals trained in radiation therapy in leading clinics in Israel and the United States.

For more information:

Related Content

IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
ASTRO 2018 Radiation Therapy Clinical Trials
Feature | ASTRO | October 08, 2018
October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies tha
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...